TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 2.87 -0.1 (3.37%)
Previous Close $2.97    52 Week High
Open $2.90    52 Week Low
Day High $3.00    P/E N/A 
Day Low $2.87    EPS
Volume 38,973